Last updated: October 2026
Your medical provider may recommend personalized dosages of compounded semaglutide based on a medical review. Compounded drugs are not FDA approved and are not evaluated for safety, effectiveness, or quality standards.
This page is a summary. It does not contain all information about compounded semaglutide, including all possible side effects, drug interactions and risks. It is not medical advice and does not replace the judgment of your health care provider. Talk with your provider or pharmacist before you start, change or stop this medication.
Indications and Use:
Compounded semaglutide is an injectable prescription medicine that your provider may prescribe for adults, together with a reduced-calorie diet and increased physical activity as part of a weight-management plan. Its effect on body weight, on long-term health outcomes and on how long weight change lasts has not been established for the compounded semaglutide formulations.
At lower doses may be considered when your prescribing clinician determines it is clinically appropriate for your individual medical needs. The safety and effectiveness of lower-dose compounded semaglutide regimens have not been established.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Your provider will decide whether this medication is appropriate for you based on your body mass index (BMI), your other medical conditions and your full medical history.
Do not use compounded semaglutide together with other semaglutide-containing products or any other GLP-1/GIP receptor agonist medicines. It is not known if compounded semaglutide is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products. It has not been studied in people who have had pancreatitis. It is not for use in anyone under 18 years of age or those 75 years of age or older
Lower dose compounded semaglutide may be considered for certain patients when the prescribing clinician determines that a patient-specific dose is clinically appropriate. The safety and effectiveness of lower dosed of compounded semaglutide has not been established. Compounded semaglutide is prescribed only for weight management in specific adult patients who meet the clinical criteria and have been evaluated by a provider. Compounded semaglutide is not FDA-approved, and the FDA has not evaluated this compounded formulation for dosing regimen safety, effectiveness or quality for any use. Certain FDA-approved semaglutide products have separate approved indications, including type 2 diabetes and reduction of cardiovascular risk in specified patient populations. Those approvals do not apply to compounded semaglutide.
Important Safety Information for Compounded Semaglutide injection
Current/Recent Prescriptions
If you have any current/recent prescriptions for either compounded or brand name weight loss medications, do not take both medications. You will be asked to provide evidence of the current/recent prescription including dose specifics. Taking two or more GLP-1/GIP medications at the same time increases the risk of potentially serious side effects. Notify your provider immediately if you have any current or previous prescriptions for compounded or brand name weight loss medications.
Medical History
Your provider can only assess whether this medicine is safe for you if your medical history is complete and accurate. Leaving out or misstating information about your health can lead to serious harm. Please answer every question fully.
Warning: Risk of Thyroid C-Cell Tumors
In studies with mice and rats, semaglutide caused thyroid tumors, including thyroid cancer. It is not known if compounded semaglutide will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Tell your provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
Do not use compounded semaglutide if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Is Compounded Semaglutide FDA-approved?
Compounded semaglutide is not FDA approved. Unlike FDA-approved medicines, it has not been reviewed by the FDA for safety and effectiveness, and the pharmacy that prepares it is not required to follow the FDA manufacturing standards that apply to approved drug products. Limitations of Use: Compounded semaglutide should not be used in combination with other semaglutide-containing products or any other GLP-1/GIP receptor agonist medicines.
· The safety and efficacy of coadministration with other products for weight loss have not been established.
· Compounded semaglutide has not been studied in patients with a history of pancreatitis.
Note: Compounded medications are not FDA approved and do not have indications for treatment as an FDA approved medication would. The above are suggestions for use of compounded semaglutide while the FDA approved therapies remain on shortage.
Who should not use compounded semaglutide?
Do not use compounded semaglutide if:
· You or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
· You have had an allergic reaction to semaglutide or to any ingredient in this compounded product. Ask your pharmacy for a full list of ingredients.
· You are pregnant, trying to become pregnant, or breastfeeding.
· You are under 18 years of age.
How should compounded injectable semaglutide be administered?
Compounded semaglutide may be taken with or without food. It is supplied in a vial. You draw up the dose and self-administer it with a needle and syringe as an injection under the skin (subcutaneous) of the stomach, thigh, or upper arm, once a week on the same day each week. Your provider will guide you on a treatment plan that may include a dose increase over time. s.
You should not change your dosing regimen or stop taking compounded semaglutide as prescribed without discussing with your provider first.
Important: How your dose is measured
Compounded semaglutide does not come in the same strength or concentration as FDA-approved pens, and serious overdoses have been reported when patients calculated their own dose. Your dose is written on your prescription label in strength (mg) or units injected of a particular concentration, to draw up in a syringe. If your label, syringe and your provider’s instruction do not match or if you have questions on how much mediation to pull up, do not inject. Call your pharmacy first.
What should I tell my provider before using compounded semaglutide?
Compounded semaglutide has certain drug interactions. It’s important to tell your provider all of the medications you are currently taking, including prescription, over-the-counter medications, vitamins, and herbal and dietary supplements.
Some medications to watch out for include:
· Medications used to treat type 1 or type 2 diabetes, including insulin or sulfonylureas (such as Amaryl or Glucotrol XL).
· Compounded semaglutide causes a delay in gastric emptying, so it has the potential to impact the absorption of medications that are taken by mouth at the same time. Your provider can guide you on how to schedule your medications.
· Other GLP-/GIP medications, including Wegovy® (semaglutide), Ozempic® (semaglutide), Saxenda® (liraglutide), Zepbound® (tirzepatide), Mounjaro® (tirzepatide), Victoza® (liraglutide), Byetta® (exenatide), or Bydureon® (exenatide).
· If you’re using other products for weight loss, including dietary supplements.
It’s important to share your entire medical history with your provider. In particular, tell your provider if you have a past history of:
· Type 1 or type 2 diabetes
· Thyroid cancer
· Pancreatitis
· Kidney disease
· Diabetic retinopathy
· Depression
· Suicidal thoughts or behavior
Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding.
· If you are pregnant: Compounded semaglutide should not be used during pregnancy. Based on animal studies, there may be potential risks to an unborn baby from exposure to compounded semaglutide during pregnancy. There is no benefit to weight loss during pregnancy and it may cause harm to the unborn baby.
· If you are a female or male of reproductive potential: Discontinue compounded semaglutide at least 2 months before a planned pregnancy since the drug can stay in the bloodstream for a long time.
· If you are breastfeeding: Compounded semaglutide was found in the milk of lactating rats. Tell your provider if you are breastfeeding before you start compounded semaglutide. At this time, we do not recommend taking compounded semaglutide if you are breastfeeding or bottle-feeding with breastmilk.
Withholding or providing inaccurate information about your health and medical history in order to obtain treatment may result in harm, including, in some cases, death.
What are the most serious side effects that I or a caregiver should monitor for when taking compounded semaglutide?
The most common side effects are typically mild and usually resolve after
the first several weeks of treatment. These can include nausea, vomiting,
diarrhea, constipation, abdominal pain, upset stomach, abdominal distension,
reflux, headache, fatigue, and dizziness. Swelling, redness, and itchiness at
the injection site may occur. The FDA has issued its most serious warning
(called a BOXED WARNING) that GLP-1s may be associated with a type of
thyroid cancer called medullary thyroid carcinoma. So far, this side effect has
primarily been seen in laboratory studies using rodents, so the risk to humans
has not been determined.
SIDE EFFECTS:
Nausea, vomiting, stomach upset,
diarrhea, tiredness, dizziness, or constipation may occur. Nausea usually
lessens as you continue to use semaglutide. If any of these effects last or
get worse, tell your provider or pharmacist promptly. Remember that this
medication has been prescribed because your provider has judged that the
benefit to you is greater than the risk of side effects. Many people using this
medication do not have serious side effects. Vomiting/diarrhea that doesn’t
stop may result in dehydration. Contact your provider promptly if you notice
any symptoms of dehydration, such as unusual dry mouth/thirst or dizziness/
lightheadedness. Tell your provider right away if you have any serious side
effects, including: signs of kidney problems (such as change in the amount
of urine), vision changes (such as decreased/blurred vision), fast heartbeat,
mental/mood changes (such as depression, thoughts of suicide), signs of low
blood sugar (sudden sweating, shaking, fast heartbeat, hunger, blurred vision,
dizziness,tingling hands/feet).
Get medical help right away if you have any very serious side effects,
including: signs of pancreas or gallbladder disease (such as nausea/vomiting
that doesn’t stop, severe stomach/abdominal pain).
A very serious allergic reaction to this drug is rare. However, get medical help
right away if you notice any symptoms of a serious allergic reaction, including:
rash, itching/swelling (especially of the face/tongue/throat), severe dizziness,
trouble breathing.
This is not a complete list of possible side effects. If you notice other effects
not listed above, contact your provider or pharmacist.
In the US - Call your provider for medical advice about side effects. You may
report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch
WARNING:
This medication has been found to cause a certain type of thyroid
tumor (thyroid C-cell tumors) in rats and mice. It is unknown if this medication
can cause similar tumors in humans. Talk with your provider about the
benefits and risks of treatment with this medication. This medication should
not be used by people with a personal/family history of a certain type of
cancer (medullary thyroid carcinoma) or by people with a certain inherited
disease (Multiple Endocrine Neoplasia syndrome type 2 or MEN 2). While
using this medication, tell your provider right away if you notice any signs or
symptoms of thyroid tumors, including unusual growth or lump in the neck,
difficulty swallowing, shortness of breath, or unusual/lasting hoarseness
If you are experiencing a medical emergency, call 911 or seek immediate medical attention.
These serious side effects can occur with compounded semaglutide. You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dose changes.
· Thyroid C-Cell Tumors: In mice and rats, semaglutide caused an increase in thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). It is unknown whether compounded semaglutide causes thyroid C-cell tumors in humans. There were cases of MTC reported in patients who took liraglutide (the active ingredient in Victoza® and Saxenda®) after the drug was put on the market. Compounded semaglutide is contraindicated in patients with a family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
· Inflammation of Pancreas (Acute Pancreatitis): Monitor for signs of acute pancreatitis, including severe abdominal pain that does not go away, sometimes radiating to the back, with or without vomiting.
· Acute Gallbladder Disease: Compounded semaglutide may cause gallbladder problems, including gallstones. Some gallbladder problems require surgery. Tell your provider right away if you have pain in your upper stomach, yellowing of skin or eyes (jaundice), fever, or clay-colored stools.
· Low Blood Sugar (Hypoglycemia): Compounded semaglutide lowers blood glucose. It can cause low blood sugar in patients with type 2 diabetes who also take another glucose control medication. Monitor your blood sugar and watch out for signs of too low blood sugar such as dizziness, blurred vision, mood changes, sweating, or fast heartbeat.
· Acute Kidney Injury: In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems to get worse. It is important for you to drink plenty of water to help reduce your chance of dehydration.
· **Serious Allergic Reactions:**Stop using compounded semaglutide right away if you experience symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, severe rash or itching, very rapid heartbeat, problems breathing or swallowing, or fainting or feeling dizzy.
· Diabetic Retinopathy Complications in Patients with Type 2 Diabetes: If you have type 2 diabetes, tell your provider right away if you experience changes in vision.
· **Increase in Heart Rate:**Tell your provider right away if you have a racing heartbeat while at rest.
· **Suicidal Behavior and Ideation:**You should pay attention to any mental health changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you.
· Never Share a Vial/Needle/Syringe: Sharing poses a risk of infection.
Before using Compounded Semaglutide
· Your healthcare provider will direct you to instructions on how to administer your compounded GLP-1 therapy.
· Tell your healthcare provider if you are taking medicines to treat diabetes including insulin or sulfonylureas which could increase your risk of low blood sugar. Talk to your healthcare provider about low blood sugar levels and how to manage them.
· If you take birth control pills by mouth, talk to your healthcare provider before you use compounded semaglutide. Birth control pills may not work as well while using compounded semaglutide. Your healthcare provider may recommend another type of birth control for 4 weeks after you start compounded semaglutide and for 4 weeks after each increase in your dose of compounded semaglutide.
Review these questions with your healthcare provider:
· Do you have other medical conditions, including problems with your pancreas or kidneys, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food?
· Do you take diabetes medicines, such as insulin or sulfonylureas?
· Do you have a history of diabetic retinopathy?
· Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?
· Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? Compounded semaglutide may harm your unborn baby. Tell your healthcare provider if you become pregnant while using compounded semaglutide. It is not known if compounded semaglutide passes into your breast milk. You should talk with your healthcare provider about the best way to feed your baby while using compounded semaglutide.
How to take compounded injectable semaglutide
· Read the instructions that come with compounded semaglutide.
· Use compounded semaglutide exactly as your healthcare provider says.
· Compounded semaglutide is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm.
· Use compounded injectable semaglutide 1 time each week on the same day every week or as directed by your provider.
· Change (rotate) your injection site with each weekly injection. Do not use the same site for each injection.
· If you take too much compounded semaglutide, call your healthcare provider, seek medical advice promptly, or contact a Poison Center expert right away at 1-800-222-1222.
HOW IS COMPOUNDED SEMAGLUTIDE PRESCRIBED?
Patient-specific compounded semaglutide typically starts at a low dose that is gradually increased over time.
Follow the dosing instructions from your provider, as they may personalize your plan for your individual needs.
Legal Disclaimers:
Compounded semaglutide is not approved by the FDA. The FDA does not evaluate compounded products for safety, effectiveness, or quality.
Zepbound is a registered trademark of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S.
Compounded tirzepatide is an injectable prescription medicine that acts as a synthetic glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptor agonist. Your provider may prescribe compounded tirzepatide for adults, together with a reduced-calorie diet and increased physical activity, as part of a weight-management plan, if clinically appropriate based on a complete medical evaluation of your BMI and other medical conditions.
Compounded medications are not FDA-approved, and the FDA has not reviewed compounded tirzepatide for safety, effectiveness, or quality. FDA-approved tirzepatide products have their own approved uses. The effects of compounded tirzepatide on body weight and long-term health outcomes, and its safety and effectiveness, have not been established.
Compounded tirzepatide should not be used with other tirzepatide-containing products or any other GLP-1/GIP receptor agonist medicines. It is not known if compounded tirzepatide is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products. It is not known if compounded tirzepatide can be used in people who have had pancreatitis. It is not known if compounded tirzepatide is safe and effective for use in children under 18 years of age or those 75 years of age or older.
Important Safety Information for Compounded tirzepatide injection
Warning: Risk of Thyroid C-Cell Tumors
· In studies with mice and rats, tirzepatide caused thyroid tumors, including thyroid cancer. It is not known if compounded tirzepatide will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Tell your provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
· Do not use compounded tirzepatide if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Is Compounded tirzepatide FDA-approved?
Compounded tirzepatide is not FDA approved and has no FDA-approved indications. The FDA has not reviewed the compounded formulation for its dosing for safety, effectiveness or quality.
Limitations of Use:
· Compounded tirzepatide should not be used in combination with other tirzepatide-containing products or any other GLP-1/GIP receptor agonist medicines.
· The safety and efficacy of coadministration with other products for weight loss have not been established.
· Compounded tirzepatide has not been studied in patients with a history of pancreatitis.
Who should not use compounded tirzepatide?
Do not use compounded tirzepatide if:
· You or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
· You have a known allergic reaction to compounded tirzepatide.
Do not use this weight-management therapy during pregnancy.
You may take compounded tirzepatide with or without food. For a vial, draw up only the prescribed dose using the syringe supplied or specified by the pharmacy. Inject under the skin of the abdomen, thigh, or the back of your upper arm as directed by your provider. Follow your prescription label and your provider’s dosing instructions. Your provider will guide you on a treatment regimen that may include increases in your dose. Do not increase your dose or change your dosing schedule on your own. Contact your provider before changing treatment, except when the emergency or stop-use instructions below apply.
Important dose measurement information
Concentrations may differ between compounded products and refills. Confirm your dose in milligrams (mg), the volume in milliliters (mL), and the correct syringe marking with your pharmacist. Syringe units are not milligrams. If the label, syringe, or instructions do not match, do not inject; call your pharmacy. Do not calculate a dose from another product or an online dosing chart.
Follow your pharmacy’s storage instructions, beyond-use date, and instructions after first puncture. Ask your pharmacy about any temperature excursion or change in appearance before using the medicine. Use a new needle and syringe for each injection. Ask your pharmacist what to do if you miss a dose; do not double your dose.
What should I tell my provider before using compounded tirzepatide?
· Compounded tirzepatide has certain drug interactions. It’s important to tell your provider all of the medications you are currently taking, including prescription, over-the-counter medications, vitamins, and herbal and dietary supplements.
Some medications to watch out for include:
· Medications used to treat type 1 or type 2 diabetes, including insulin or sulfonylureas (such as Amaryl or Glucotrol XL).
· Compounded tirzepatide causes a delay in gastric emptying, so it has the potential to impact the absorption of medications that are taken by mouth at the same time. Your provider can guide you on how to schedule your medications.
· Other GLP-/GIP medications, including Wegovy® (semaglutide), Ozempic® (semaglutide), Saxenda® (liraglutide), Zepbound® (tirzepatide), Mounjaro® (tirzepatide), Victoza® (liraglutide), Byetta® (exenatide), or Bydureon® (exenatide).
· If you’re using other products for weight loss, including dietary supplements.
It’s important to share your entire medical history with your provider. In particular, tell your provider if you have a past history of:
· Type 1 or type 2 diabetes
· Thyroid cancer
· Pancreatitis
· Kidney disease
· Diabetic retinopathy
· Depression
· Suicidal thoughts or behavior
Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding.
· If you are pregnant: Compounded tirzepatide should not be used during pregnancy. Based on animal studies, there may be potential risks to an unborn baby from exposure to compounded tirzepatide during pregnancy. There is no benefit to weight loss during pregnancy and it may cause harm to the unborn baby.
If you are planning a pregnancy, talk with your provider before trying to become pregnant about when to stop tirzepatide. If you become pregnant, stop using this medication and contact your provider promptly.
· If you are a female or male of reproductive potential: Discontinue compounded tirzepatide at least 2 months before a planned pregnancy since the drug can stay in the bloodstream for a long time.
· If you are breastfeeding: discuss treatment with your provider before use. At this time, we do not recommend taking compounded tirzepatide if you are breastfeeding or bottle-feeding with breastmilk.
Your provider needs complete and accurate information to assess whether treatment is appropriate. Please answer all medical-history questions fully.
What are the most serious side effects that I or a caregiver should monitor for when taking compounded tirzepatide?
Possible side effects include nausea, vomiting, diarrhea, constipation, abdominal discomfort, reflux, fatigue, injection site reactions, belching, and hair loss.
Contact your provider if symptoms persist or worsen. Serious reactions require the actions below. This is not a complete list of effects. Report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
If you are experiencing a medical emergency, call 911 or seek immediate medical attention.
These serious side effects can occur with compounded tirzepatide. You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dose changes.
Thyroid C-Cell Tumors: In mice and rats, tirzepatide caused an increase in thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). It is unknown whether compounded tirzepatide causes thyroid C-cell tumors in humans. There were cases of MTC reported in patients who took liraglutide (the active ingredient in Victoza® and Saxenda®) after the drug was put on the market. Compounded tirzepatide is contraindicated in patients with a family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
Inflammation of Pancreas (Acute Pancreatitis): Monitor for signs of acute pancreatitis, including severe abdominal pain that does not go away, sometimes extending to your back, with or without vomiting. Stop using tirzepatide and seek medical care immediately if this occurs.
Acute Gallbladder Disease: Compounded tirzepatide may cause gallbladder problems, including gallstones. Some gallbladder problems require surgery. Tell your provider right away if you have pain in your upper stomach, yellowing of skin or eyes (jaundice), fever, or clay-colored stools.
Low Blood Sugar (Hypoglycemia): Compounded tirzepatide lowers blood glucose. It can cause low blood sugar in patients with type 2 diabetes who also take another glucose control medication. Monitor your blood sugar and watch out for signs of too low blood sugar such as dizziness, blurred vision, mood changes, sweating, or fast heartbeat.
Acute Kidney Injury: In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems to get worse. It is important for you to drink plenty of water to help reduce your chance of dehydration.
**Serious Allergic Reactions:**Stop using compounded tirzepatide right away if you experience symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, severe rash or itching, very rapid heartbeat, problems breathing or swallowing, or fainting or feeling dizzy.
Diabetic Retinopathy Complications in Patients with Type 2 Diabetes: If you have type 2 diabetes, tell your provider right away if you experience changes in vision.
Severe stomach problems: Tell your provider about severe or persistent digestive symptoms. Tirzepatide is not recommended for severe gastroparesis (very slow stomach emptying)
Procedures and Anesthesia: Tell your surgical and anesthesia teams that you take tirzepatide. Delayed stomach emptying may increase the risk of stomach contents entering the lungs during anesthesia or deep sedation.
**Increase in Heart Rate:**Tell your provider right away if you have a racing heartbeat while at rest.
**Suicidal Behavior and Ideation:**You should pay attention to any mental health changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you.
Never Share a Vial/Needle/Syringe: Sharing poses a risk of infection.
Before using Compounded tirzepatide
· Your healthcare provider will direct you to instructions on how to administer your GLP-1 therapy.
· Tell your healthcare provider if you are taking medicines to treat diabetes including insulin or sulfonylureas which could increase your risk of low blood sugar. Talk to your healthcare provider about low blood sugar levels and how to manage them.
· If you take birth control pills by mouth, talk to your healthcare provider before you use compounded tirzepatide. Birth control pills may not work as well while using compounded tirzepatide. Your healthcare provider may recommend another type of birth control for 4 weeks after you start compounded tirzepatide and for 4 weeks after each increase in your dose of compounded tirzepatide.
Review these questions with your healthcare provider:
· Do you have other medical conditions, including problems with your pancreas or kidneys, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food?
· Do you take diabetes medicines, such as insulin or sulfonylureas?
· Do you have a history of diabetic retinopathy?
· Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?
· Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? Compounded tirzepatide may harm your unborn baby. Tell your healthcare provider if you become pregnant while using compounded tirzepatide. It is not known if compounded tirzepatide passes into your breast milk. You should talk with your healthcare provider about the best way to feed your baby while using compounded tirzepatide.
How to take compounded tirzepatide injection
· Read the instructions that come with compounded tirzepatide.
· Use compounded tirzepatide exactly as your healthcare provider says.
· Compounded tirzepatide is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm.
· Use compounded tirzepatide as instructed by your provider
· Change (rotate) your injection site with each weekly injection. Do not use the same site for each injection.
· If you take too much compounded tirzepatide, call your healthcare provider, seek medical advice promptly, or contact a Poison Center expert right away at 1-800-222-1222.
HOW IS compounded tirzepatide PRESCRIBED?
Compounded tirzepatide typically starts at a low dose that is gradually increased over
time, but your provider will determine your individualized treatment.
Follow the dosing instructions from your provider, as they may personalize your plan for your individual needs.
Legal Disclaimers:
Compounded tirzepatide is not approved by the FDA. The FDA does not evaluate compounded products for safety, effectiveness, or quality.
Zepbound is a registered trademark of Eli Lilly and Company. Mounjaro is a registered trademark of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Victoza and Saxenda are registered trademarks of Novo Nordisk A/S. Byetta is a registered trademark of AstraZeneca AB.
Important: Always follow the guidance of your healthcare provider before starting or adjusting any medication regimen.
Materials you will need:
Step 1: Prepare your injection area
Tip: Rotate injection sites (e.g. right to left, glute to deltoid to thigh) to prevent tissue damage and irritation.
Step 2: Prepare the syringe
Step 3: Administer the injection (see written and video instructions for subcutaneous injection)
Step 4: Post-injection care
Step 5: Post-injection monitoring and safety
Tips for a successful injection:
1. How does the lab process work?
2. What is testosterone? Testosterone is a hormone primarily produced in the testes in men and, to a lesser extent, in the ovaries in women. It plays a crucial role in the development of male reproductive tissues, secondary sexual characteristics (such as muscle mass, bone density, and body hair), and overall well-being. In both men and women, testosterone is vital for maintaining muscle strength, energy levels, and libido.
3. How is testosterone administered? Testosterone can be administered through various methods, including:
4. Why is it important to move injection sites? Rotating injection sites is essential to prevent tissue damage, irritation, or the development of scar tissue at the injection site. Repeated injections in the same area can lead to complications such as infections or lumps, making absorption of testosterone less effective.
5. What are the side effects of testosterone? Common side effects of testosterone therapy may include acne, oily skin, hair loss, increased body hair, mood changes, increased estradiol levels, testicular atrophy. More serious side effects can include an increase in red blood cell count, sleep apnea, or an enlarged prostate in men. Testosterone therapy may increase the risk of increased blood pressure. It's important to monitor these effects with your healthcare provider to adjust treatment as necessary.
6. What is the negative feedback loop? The negative feedback loop refers to the body's natural regulatory mechanism that maintains hormone balance. When testosterone levels rise due to hormone replacement therapy, the hypothalamus and pituitary gland may reduce the natural production of testosterone. This can lead to a reliance on therapy for maintaining testosterone levels and may affect one's ability to get their partner pregnant.
7. How does testosterone affect fertility? Testosterone therapy can negatively impact fertility by suppressing the natural production of sperm. This is due to the aforementioned negative feedback loop, where the increased testosterone levels signal the body to reduce the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), both of which are crucial for sperm production.
8. What is meant by transference when someone applies topical testosterone? Transference refers to the unintentional transfer of testosterone from one person to another through direct skin contact. If someone has applied topical testosterone and then touches another person, the hormone can transfer to that person's skin, potentially causing unwanted effects. To prevent this, it's important to wash hands thoroughly after application and avoid skin contact with others in the area where the cream was applied. In addition, testosterone can be transferred by vaporization for 4-6 hours after application. Thus, it is essential to avoid contact or proximity with small children after application.
9. What increases PSA levels?
Prostate-specific antigen (PSA) is a protein produced by the prostate gland, and its levels in the blood can be an indicator of prostate health. While elevated PSA levels can be associated with prostate cancer, they can also be influenced by several other factors:
Prostate cancer: Elevated PSA levels can be an indicator of prostate cancer, particularly when the increase is significant or when it occurs rapidly. However, PSA is not a definitive marker for cancer, and elevated levels can occur for benign reasons as well.
Important Safety Information for Zepbound® (tirzepatide) injection Warning: Risk of Thyroid C-Cell Tumors
In rats, Zepbound® (tirzepatide) caused thyroid tumors, including thyroid cancer. It is not known if Zepbound® (tirzepatide) will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Tell your provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. Do not use Zepbound® (tirzepatide) if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
What is the FDA-approved use of Zepbound® (tirzepatide)?
Zepbound® (tirzepatide) is used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of:
Limitations of use:
Who should not use Zepbound® (tirzepatide)?
Do not use Zepbound® (tirzepatide) if:
How should I take Zepbound® (tirzepatide)?
You can take Zepbound® with or without food. The pre-filled injector pen is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. Your Spa City Aesthetics provider will guide you on a treatment regimen that may include an increase in dose every four weeks. You should not change your dosing regimven or stop taking Zepbound® (tirzepatide) as prescribed without discussing with your provider first.
What should I tell my Spa City Aesthetics provider before using Zepbound® (tirzepatide)?
Zepbound® (tirzepatide) has certain drug interactions.It's important to tell your Spa City Aesthetics provider all of the medications you are currently taking, including prescription, over-the-counter medications, vitamins, and herbal and dietary supplements.
Some medications to watch out for include:
Withholding or providing inaccurate information about your health and medical history in order to obtain treatment may result in harm, including, in some cases, death.
What are the most serious side effects that I or a caregiver should monitor for when taking Zepbound® (tirzepatide)?
If you are experiencing a medical emergency, call 911 or seek immediate medical attention.
These serious side effects are rare, but can occur with Zepbound® (tirzepatide). You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dose changes.
What are the most common side effects of Zepbound® (tirzepatide)?
You are encouraged to report negative side effects of prescription products to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
This information is not comprehensive. Please see the full Prescribing Information for complete safety information.
Disclaimer: Ozempic®, WeGovy®, Saxenda® and Victoza® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly. Spa City Aesthetics Health has no affiliation with Novo Nordiskor Eli Lilly . The compounded products available as part of Spa City Aesthetics Health's Weight Loss Program are not made by Novo Nordiskor Eli Lilly or any company affiliated with Novo Nordisk or Eli Lilly .
Warning: Risk of Thyroid C-Cell Tumors
What is the FDA-approved use of Wegovy® (semaglutide)?
Wegovy® (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of:
Limitations of use:
Who should not use Wegovy® (semaglutide)?
Do not use Wegovy® (semaglutide) if:
How should Wegovy® (semaglutide) be administered?
You can take Wegovy® (semaglutide) with or without food. The pre-filled injector pen is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. Your Spa City Aesthetics provider will guide you on a treatment regimen that may include an increase in dose every four weeks. You should not change your dosing regimen or stop taking Wegovy® (semaglutide) as prescribed without discussing with your provider first.
What should I tell my Spa City Aesthetics provider before using Wegovy® (semaglutide)?
Wegovy® (semaglutide) has certain drug interactions. It's important to tell your Spa City Aesthetics provider all of the medications you are currently taking, including prescription, over-the-counter medications, vitamins, and herbal and dietary supplements.
Some medications to watch out for include:
It's important to share your entire medical history with your provider. In particular, tell your provider if you have a past history of:
Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding.
Pregnancy registry: There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to semaglutide (the active ingredient in Wegovy® and Ozempic®) during pregnancy. Pregnant women exposed to these products and healthcare providers are encouraged to contact Novo Nordisk at 1-800-727-6500.
Withholding or providing inaccurate information about your health and medical history in order to obtain treatment may result in harm, including, in some cases, death.
What are the most serious side effects that I or a caregiver should monitor for when taking Wegovy® (semaglutide)?
If you are experiencing a medical emergency, call 911 or seek immediate medical attention.
These serious side effects can occur with Wegovy® (semaglutide). You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dose changes.
What are the most common side effects of Wegovy® (semaglutide)?
You are encouraged to report negative side effects of prescription products:
This information is not comprehensive. Please see the full Prescribing Information for complete safety information.
Disclaimer: Ozempic®, WeGovy® and Saxenda® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly. Spa City Aesthetics Health has no affiliation with Novo Nordiskor Eli Lilly . The compounded products available as part of Spa City Aesthetics Health's Weight Loss Program are not made by Novo Nordiskor Eli Lilly or any company affiliated with Novo Nordiskor Eli Lilly .
Important Safety Information for Mounjaro® (tirzepatide) injection
Warning: Risk of Thyroid C-Cell Tumors
Mounjaro® (tirzepatide) injection may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.
What is the FDA-approved use of Mounjaro® (tirzepatide) injection?
Mounjaro® (tirzepatide) injection (mown-JAHR-OH) is an injectable medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).
Limitations of use:
It is not known if Mounjaro® (tirzepatide) injection can be used in people who have had inflammation of the pancreas (pancreatitis). Mounjaro® (tirzepatide) injection is not for use in people with type 1 diabetes. It is not known if Mounjaro® (tirzepatide) injection is safe and effective for use in children under 18 years of age.
Who should not use Mounjaro® (tirzepatide) injection?
Do not use Mounjaro® (tirzepatide) injection if:
How should I take Mounjaro® (tirzepatide) injection?
You can take Mounjaro® (tirzepatide) injection with or without food. The pre-filled injector pen is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. You should change your injection site each week. Do not use the same site for each injection. Your Spa City Aesthetics provider will guide you on a treatment regimen that may include an increase in dose every four weeks.
You should not change your dosing regimen or stop taking Mounjaro® (tirzepatide) injection as prescribed without discussing with your provider first. If you take too much Mounjaro® (tirzepatide) injection, call your healthcare provider or seek medical advice promptly.
What should I discuss with my Spa City Aesthetics provider before using Mounjaro®?
Some medications to watch out for include:
Withholding or providing inaccurate information about your health and medical history in order to obtain treatment may result in harm, including, in some cases, death.
What are the most serious side effects that I or a caregiver should monitor for when taking Mounjaro® (tirzepatide) injection?
If you are experiencing a medical emergency, call 911 or seek immediate medical attention. These serious side effects are rare, but can occur with Mounjaro® (tirzepatide) injection. You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dose changes.
What are the most common side effects of Mounjaro® (tirzepatide) injection?
You are encouraged to report negative side effects of prescription products to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
This information is not comprehensive. Please see the full Prescribing Information for complete safety information.
Disclaimer: Ozempic®, WeGovy® and Saxenda® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly. Spa City Aesthetics Health has no affiliation with Novo Nordiskor Eli Lilly . The compounded products available as part of Spa City Aesthetics Health's Weight Loss Program are not made by Novo Nordiskor Eli Lilly or any company affiliated with Novo Nordiskor Eli Lilly .
Important Safety Information for Ozempic® (semaglutide) injection
Warning: Risk of Thyroid C-Cell Tumors
Mounjaro® (tirzepatide) injection may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.
Ozempic® (semaglutide) may cause serious side effects, including: Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Ozempic® (semaglutide) and medicines that work like Ozempic® (semaglutide) caused thyroid tumors, including thyroid cancer. It is not known if Ozempic® (semaglutide) will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
Do not use Ozempic® (semaglutide) if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
What is the FDA-approved use of Ozempic® (semaglutide)?
Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine used:
Limitations of use:
It is not known if Ozempic® (semaglutide) can be used in people who have had pancreatitis. Ozempic® (semaglutide) is not for use in people with type 1 diabetes. It is not known if Ozempic® (semaglutide) is safe and effective for use in children under 18 years of age.
Who should not use Ozempic® (semaglutide)?
Do not use Ozempic® (semaglutide) if:
How should I take Ozempic® (semaglutide)?
You can take Ozempic® (semaglutide) with or without food. The pre-filled injector pen is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. You should change your injection site each week. Do not use the same site for each injection. Your Spa City Aesthetics provider will guide you on a treatment regimen that may include an increase in dose every four weeks.
You should not change your dosing regimen or stop taking Ozempic® (semaglutide) as prescribed without discussing with your provider first. If you take too much Ozempic® (semaglutide), call your healthcare provider or seek medical advice promptly.
What should I discuss with my Spa City Aesthetics provider before using Ozempic® (semaglutide)?
Some medications to watch out for include:
Withholding or providing inaccurate information about your health and medical history in order to obtain treatment may result in harm, including, in some cases, death.
What are the most serious side effects that I or a caregiver should monitor for when taking Ozempic® (semaglutide)?
If you are experiencing a medical emergency, call 911 or seek immediate medical attention.
These serious side effects are rare, but can occur with Ozempic® (semaglutide). You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dose changes.
What are the most common side effects of Ozempic® (semaglutide)?
You are encouraged to report negative side effects of prescription products to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
This information is not comprehensive. Please see the full Prescribing Information for complete safety information.
Disclaimer: Ozempic®, WeGovy®, Saxenda® and Victoza® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly. Spa City Aesthetics Health has no affiliation with Novo Nordiskor Eli Lilly . The compounded products available as part of Spa City Aesthetics Health's Weight Loss Program are not made by Novo Nordiskor Eli Lilly or any company affiliated with Novo Nordiskor Eli Lilly .